Showing Results for
- Academic Journals (74)
Search Results
- 74
Academic Journals
- 74
- Search Terms:
- 1From: Nature Biotechnology. (Vol. 28, Issue 1) Peer-ReviewedAuthor(s): Catherine Shaffer 1 Author Affiliations: (1) Ann Arbor, A survey published in the November issue of the journal Health Affairs reports that academic researchers' links with industry are on the ebb...
- 2From: Nature Biotechnology. (Vol. 28, Issue 1) Peer-ReviewedAuthor Affiliations: David Schubert replies: Suzanne Harris has four concerns about my letter in the September 2009 issue of Nature Biotechnology 1. She claims that I implied Parrott's comments were made as a...
- 3From: Nature Biotechnology. (Vol. 28, Issue 1) Peer-ReviewedAuthor Affiliations: Recent patent applications in induced pluripotent stem (iPS) cells Table 1 Recent patent applications in synthetic biology WO 2009137624 A method of generating and expanding human...
- 4From: Nature Biotechnology. (Vol. 28, Issue 1) Peer-ReviewedAuthor Affiliations: Michael Moore (right) has been named nonexecutive chairman of Oxford BioTherapeutics (Oxford, UK). Moore brings several decades of senior management experience in the biotech sector and joins the...
- 5From: Nature Biotechnology. (Vol. 28, Issue 1) Peer-ReviewedAuthor(s): Craig Mak, Markus Elsner, Laura DeFrancesco, Peter Hare Author Affiliations: Short-read genome assembler A novel algorithm lies behind recent insights into the genomes of the giant panda...
- 6From: Nature Biotechnology. (Vol. 28, Issue 1) Peer-ReviewedAuthor(s): Suzanne Harris 1 Author Affiliations: (1) International Life Sciences Institute, Washington, USA To the Editor: As executive director, and on behalf, of the International Life Sciences Institute (ILSI;...
- 7From: Nature Biotechnology. (Vol. 28, Issue 1) Peer-ReviewedWith the advent of ever more detailed maps of cellular signaling pathways, it has become apparent that sophisticated analysis methods are needed to understand the behavior of the whole system. Approaches based on...
- 8From: Nature Biotechnology. (Vol. 28, Issue 1) Peer-ReviewedSmall and medium-sized companies listing on ChiNext, a new Chinese stock market launched six weeks ago in Shenzhen, have been buffeted by investor volatility and insider trading. Despite the roller coaster ride,...
- 9From: Nature Biotechnology. (Vol. 28, Issue 1) Peer-ReviewedGene therapy vectors based on adeno-associated virus tend to accumulate in the liver, limiting their utility for targeting other organs. Using site-directed mutagenesis of the capsid surface, Asokan et al. generate a...
- 10From: Nature Biotechnology. (Vol. 28, Issue 1) Peer-ReviewedWilliam D. Young, formerly chairman and CEO of Monogram Biosciences, has been named chairman of the board of Biogen Idec (Cambridge, MA, USA), succeeding Bruce R. Ross, who has retired from the board. Young previously...
- 11From: Nature Biotechnology. (Vol. 28, Issue 1) Peer-ReviewedAffymetrix (Santa Clara, CA, USA) has named Andrew J. Last as chief commercial officer. He was previously vice president, global marketing and strategic planning of BD Biosciences' cell analysis unit and general manager...
- 12From: Nature Biotechnology. (Vol. 28, Issue 1) Peer-ReviewedThanks to a 'biotech' intervention, the modern fiddle in the picture fooled more than 100 listeners in a blind test. Professor Francis Schwarze of the Swiss Federal Laboratory for Materials Testing and Research treated...
- 13From: Nature Biotechnology. (Vol. 28, Issue 1) Peer-ReviewedRNA-mediated gene suppression is a powerful technology to suppress the expression of targeted genes within plants, as well as most other organisms. In 2002, RNA interference (RNAi) was proclaimed by Science as the...
- 14From: Nature Biotechnology. (Vol. 28, Issue 1) Peer-ReviewedTo recapitulate the stochastic nature of human cancer development, we have devised a strategy for generating mouse tumor models that involves stepwise genetic manipulation of embryonic stem (ES) cells and chimera...
- 15From: Nature Biotechnology. (Vol. 28, Issue 1) Peer-ReviewedA new metric called the normalized spectral index (SI.sub.N) provides a simple way to quantify and compare label-free proteomics data. Author(s): Mihaela E Sardiu 1 , Michael P Washburn 1 Author Affiliations:...
- 16From: Nature Biotechnology. (Vol. 28, Issue 1) Peer-ReviewedThe haploid genetic screens routinely used by yeast researchers to recognize recessive mutations have long been the envy of those working with multicellular eukaryotes. RNA interference based strategies never silence...
- 17From: Nature Biotechnology. (Vol. 28, Issue 1) Peer-ReviewedThe 4th quarter of 2008 marked one of the worst three-month stretches for US equity markets since the Great Depression. Concurrent to the markets' year-end tumble, compensation committees across the life sciences...
- 18From: Nature Biotechnology. (Vol. 28, Issue 1) Peer-ReviewedTo the Editor: Despite epidemiological intelligence and microbiological surveillance systems or programs, virus emergence mostly occurs by surprise. Influenza A virus offers a paradigm of such a situation: the world...
- 19From: Nature Biotechnology. (Vol. 28, Issue 1) Peer-ReviewedReviewing the major features in the patent landscape of RNA-mediated gene suppression may aid the development of patent strategies that will support the next generation of genetically modified crops. Author(s):...
- 20From: Nature Biotechnology. (Vol. 28, Issue 1) Peer-ReviewedChinese officials have approved a strain of genetically engineered rice, placing the country in position to be first in the world to produce biotech rice on a commercial scale. China's Ministry of Agriculture in...